Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

Oral OT and AVP Effects on Attention to Emotional Faces in Healthy Adults

Official title: Effects of Oromucosal Oxytocin and Arginine Vasopressin on Top-Down and Bottom-Up Attention to Emotional Faces: A Randomized Placebo-Controlled fMRI Study

Run by University of Electronic Science and Technology of China · NCT07838493 · Data updated 2026-11-12

This study tests whether 24 IU of oxytocin or 24 IU of vasopressin, given as an oral spray/lollipop, change how healthy adults pay attention to emotional faces compared with a placebo.

More Healhty trials

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Electronic Science and Technology of China
Academic / other
Locations1 site (Chengdu, Sichuang)
StatusRecruiting
StartedSeptember 18, 2026
Main results expectedDecember 18, 2026
Study endsDecember 22, 2026
Registry record updatedSeptember 24, 2026
Trial IDNCT07838493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults without psychiatric or neurological disorders who are eligible for MRI and willing to provide blood samples, with specific menstrual-cycle considerations for naturally cycling females.

Probably not a fit

Individuals with psychiatric or neurological conditions or MRI-incompatibilities may not experience a benefit and may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a randomized, double-blind design, healthy adults receive oxytocin, vasopressin, or placebo through an oromucosal administration, then complete behavioral tasks and undergo fMRI to study attention to emotional faces and related brain activity. The study also collects baseline and post-treatment mood and personality measures to control for individual differences. Participants have a resting period after administration before imaging, with blood samples taken prior to scanning. The protocol compares top-down and bottom-up attention patterns and neural responses across the three groups.

Why it matters

Potential benefit: If successful, findings could clarify how oromucosal OT and AVP modulate social attention, potentially informing therapies for social cognition in the future.

How similar studies have gone: Previous intranasal OT studies show modulation of social attention; this study investigates whether oromucosal delivery yields similar behavioral effects with distinct neural patterns.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy subjects without past or current psychiatric or neurological disorders
* Normal or corrected-to-normal vision
* Eligible for MRI scanning and willing to undergo blood sampling and study treatment administration
* For naturally cycling female participants, willingness and ability to complete the experimental session within the predefined menstrual-cycle phase, determined using menstrual history and urinary luteinizing hormone (LH) testing
* Willing to comply with study requirements regarding alcohol, caffeine, nicotine, medication use, and other pre-session restrictions

Exclusion Criteria:

* History of head injury or epilepsy or seizure disorders
* Current or past major psychiatric, neurological, or serious medical illness that may affect participant safety or study outcomes
* Current use of psychoactive medications, hormonal medications, or other medications that may substantially affect central nervous system or neuroendocrine function
* Regular smoking or inability to comply with the required nicotine abstinence period before testing
* Face recognition impairment or other visual-perceptual impairment that could interfere with performance of the emotional face tasks

Where it's running

  • University of Electronic Science and Technology of China
    Chengdu, Sichuang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.